Through the new Cervera 2023 call, CDTI will grant grants of up to 90% of the total approved budget.
Objective of the 2023 call
Strengthen the innovation capabilities by contracting R&D activities to knowledge-generating centers or collaborating with them for the development of R&D projects.
Beneficiaries
SMEs and MIDCAPS.
Type of aid
The Cervera 2023 call will grant partially repayable loans of up to 90% of the total budget approved by CDTI, with the following characteristics:
- Interest rate: Fixed. 1-year Euribor (fixed at the time of approval of the aid).
* If the R&D project is co-financed with community funds, the interest rate will only apply to the refundable tranche of the aid.
- Return period: 10 or 15 years.
- Amortization: Biannual.
- Advance payment: 35% of the aid with a limit of 250,000€, without the need for additional guarantees.
The non-refundable tranche may reach up to 33%, calculated on 75% of the budget. The beneficiary company may request the reasoned report once the loan agreement with the CDTI has been formalized.
Main requirements
- Projects must have a minimum fundable budget of 175,000€ and a duration of between 12 and 36 months.
- Projects may have one or more technical milestones, whose duration should be between 9 and 18 months.
- Knowledge centers must have a minimum participation of 10% of the total approved budget.
- Projects must be developed in a limited group of technological areas (Cervera* priority technologies).
*Cervera's priority technologies are defined as:
- Advanced materials
- Circular economy
- Energy transition
- Smart manufacturing
- Technologies for health
- Safe and healthy food chain
- Deep Learning and Artificial Intelligence
- Advanced mobile networks
- Intelligent transport
- Information protection
- Quantum computing.
Fundable projects
Projects of research and business development of an applied nature for the creation or significant improvement of a productive process, product or service. Projects may include industrial research and experimental development activities and must demonstrate a differential technological aspect over existing technologies in the market.
Financiable expenses
- Personnel expenses- Instrument and material costs
- Contract research costs
- Knowledge and acquired patents
- Consulting and equivalent services (excluding those associated with the project request)
- Additional overhead costs
- Other expenses derived from the project
External collaborations may not exceed 65% of the eligible budget in general. In projects in the pharmaceutical sector, these expenses may reach up to 80% of the eligible budget.
Criteria for evaluating applications
At the technical level:
- Plan for commercial exploitation of the project
- Project Technology and Innovation
- Capacity of the company in relation to the project
- Socio-economic impact assessment, gender perspective and sustainability
At the financial level:
- Analysis of the consideration of a company in crisis
- Economic-financial and risk analysis
- Economic-financial analysis of the project
- Economic-financial adaptation of the company to the activities carried out by the project.
Deadline for submitting applications
The Cervera 2023 call for grants will remain open throughout the year.